In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report), with a price target of $103.00.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Ryan Zimmerman has given his Buy rating due to a combination of factors influencing GE Healthcare Technologies Inc. The company’s recent financial performance has shown promising signs, with revenues and earnings per share exceeding expectations despite challenges in the Chinese market. The strength in the US market has helped offset these challenges, and the company has demonstrated improved profitability metrics, such as gross margins and operating margins, which have surpassed consensus estimates.
Furthermore, GE Healthcare’s orders have shown significant growth, supported by a favorable Book-to-Bill ratio, indicating a strong demand for its products and services. The management’s guidance for fiscal year 2025 suggests continued organic revenue growth and an increase in adjusted operating margins, potentially driven by easing comparisons in the first half of the year and improvements in order growth, particularly in China. This positive outlook is bolstered by an attractive valuation, as the company’s multiples are expected to align more closely with its peers in the large-cap sector, justifying the Buy rating.
According to TipRanks, Zimmerman is a 2-star analyst with an average return of 0.3% and a 46.33% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Globus Medical, Glaukos, and GE Healthcare Technologies Inc.
In another report released on February 11, Mizuho Securities also maintained a Buy rating on the stock with a $105.00 price target.